Genetic Factors Affecting Statin Intolerance
Author Information
Author(s): Oh Jisun, Ban Matthew R, Miskie Brooke A, Pollex Rebecca L, Hegele Robert A
Primary Institution: Schulich School of Medicine and Dentistry, University of Western Ontario and Vascular Biology Research Group, Robarts Research Institute
Hypothesis
Common, mild genetic variation in COQ2 would be associated with inter-individual variation in statin intolerance.
Conclusion
Genetic variation in COQ2 is associated with increased odds of statin intolerance, primarily through muscle symptoms.
Supporting Evidence
- Statin intolerance is linked to genetic variations in the COQ2 gene.
- Homozygotes for rare alleles of COQ2 SNPs have higher odds of experiencing statin intolerance.
- The study included both statin-intolerant patients and matched controls.
Takeaway
Some people can't handle statins well because of their genes, especially a gene called COQ2 that affects muscle health.
Methodology
The study involved 133 statin-intolerant subjects and 158 matched controls, analyzing genetic variations in the COQ2 gene.
Potential Biases
Potential bias due to the absence of a functional consequence of the genetic variants tested.
Limitations
The study had a small sample size and lacked a replication sample.
Participant Demographics
All subjects were self-identified as having European geographical ancestry.
Statistical Information
P-Value
0.007
Confidence Interval
95% CI for SNP1: 0.99 to 5.89; SNP2: 1.13 to 4.81; 2-SNP haplotype: 1.26 to 5.28
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website